Graham Capital Management, L.P.

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1315421 ROWAYTON, CT

Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$416,045

-$723,297 QoQ

Shares Held

24,035

-73.4% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#177

of 305 holders

Holding Since

Mar 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $4,664,055 across 12 Drug Manufacturers - Specialty & Generic names. AMRX ranks #4 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	75,653	$1,212,717
2	HLN	Haleon plc	55,057	$513,681
3	BHC	Bausch Health Companies Inc.	101,971	$502,717
4	AMRX	Amneal Pharmaceuticals, Inc. This page	24,035	$416,045
5	PBH	Prestige Consumer Healthcare Inc.	7,136	$337,318
6	COLL	Collegium Pharmaceutical, Inc	8,555	$309,691
7	ZTS	Zoetis Inc.	4,304	$309,285
8	PRGO	PERRIGO Co plc	28,290	$293,933

All Filings in AMRX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$416,045	24,035	-73.4%	Shares	Sole	2026-08-14
2025-12-31	$1,139,342	90,424	+252.1%	Shares	Sole	2026-02-17
2025-06-30	$207,759	25,681	+16.4%	Shares	Sole	2025-08-14
2023-12-31	$133,940	22,066	-26.7%	Shares	Sole	2024-02-14
2023-06-30	$93,285	30,092	+43.0%	Shares	Sole	2023-08-14
2023-03-31	$29,253	21,046	-96.1%	Shares	Sole	2023-05-15
2022-12-31	$1,064,309	534,829	+416.6%	Shares	Sole	2023-02-14
2022-03-31	$431,728	103,532	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.